Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...

--(BUSINESS WIRE)--CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines ... administered to dogs as part of combination distemper/kennel cough vaccines for decades.

“This is why many facilities and events where multiple dogs gather, such as dog shows, training centers, and boarding facilities, require proof of vaccination.” Because more than one pathogen can ...

As whooping cough cases rise in the U.S., a new nasal vaccine ... Current pertussis vaccines are widely used and effective at preventing whooping cough, caused by the Bordetella pertussis bacteria.

The immunity lasts at least 3 years but may even last the rest of your dog's life. After 3 years, you will need to get the parvo vaccine boosted. Your dog is still susceptible to the other viruses ...

are developing intranasal vaccines that harness the full breadth of the immune system to keep ... virus that is not known to cause disease in humans which has been commonly administered to dogs as ...

December 09, 2024--(BUSINESS WIRE)--CyanVac LLC, a clinical-stage biotechnology company developing intranasal ... administered to dogs as part of combination distemper/kennel cough vaccines ...

The good news is that there’s a vaccine that can significantly reduce the chances of your dog catching kennel cough. This vaccine is often required by kennels and boarding facilities ...

--(BUSINESS WIRE)--CyanVac LLC, a clinical-stage biotechnology company developing intranasal vaccines using a transformational parainfluenza ... known to cause disease in humans which has been ...

PIV5 has been commonly administered to dogs as part of combination distemper/kennel cough vaccines for decades. Blue Lake Biotechnology is developing BLB201 as an intranasal vaccine to prevent acute ...